Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Therapeutic Radiopharmaceuticals Market Insights, Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Therapeutic Radiopharmaceuticals Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Therapeutic Radiopharmaceuticals Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Type
    • 1.4.2 Radium-223
    • 1.4.3 Lutetium-177
    • 1.4.4 Iodine-131
    • 1.4.5 Other
  • 1.5 Market by Application
    • 1.5.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Application
    • 1.5.2 Thyroid
    • 1.5.3 Bone Metastasis
    • 1.5.4 Lymphoma
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Therapeutic Radiopharmaceuticals Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Therapeutic Radiopharmaceuticals Industry
      • 1.6.1.1 Therapeutic Radiopharmaceuticals Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Therapeutic Radiopharmaceuticals Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Therapeutic Radiopharmaceuticals Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Therapeutic Radiopharmaceuticals Market Size Estimates and Forecasts
    • 2.1.1 Global Therapeutic Radiopharmaceuticals Revenue 2015-2026
    • 2.1.2 Global Therapeutic Radiopharmaceuticals Sales 2015-2026
  • 2.2 Therapeutic Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Therapeutic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Therapeutic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Therapeutic Radiopharmaceuticals Competitor Landscape by Players

  • 3.1 Therapeutic Radiopharmaceuticals Sales by Manufacturers
    • 3.1.1 Therapeutic Radiopharmaceuticals Sales by Manufacturers (2015-2020)
    • 3.1.2 Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Therapeutic Radiopharmaceuticals Revenue by Manufacturers
    • 3.2.1 Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2015-2020)
    • 3.2.2 Therapeutic Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Therapeutic Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Radiopharmaceuticals Revenue in 2019
    • 3.2.5 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Therapeutic Radiopharmaceuticals Price by Manufacturers
  • 3.4 Therapeutic Radiopharmaceuticals Manufacturing Base Distribution, Product Types
    • 3.4.1 Therapeutic Radiopharmaceuticals Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Therapeutic Radiopharmaceuticals Product Type
    • 3.4.3 Date of International Manufacturers Enter into Therapeutic Radiopharmaceuticals Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Therapeutic Radiopharmaceuticals Market Size by Type (2015-2020)
    • 4.1.1 Global Therapeutic Radiopharmaceuticals Sales by Type (2015-2020)
    • 4.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Type (2015-2020)
    • 4.1.3 Therapeutic Radiopharmaceuticals Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Therapeutic Radiopharmaceuticals Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Therapeutic Radiopharmaceuticals Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Type (2021-2026)
    • 4.2.3 Therapeutic Radiopharmaceuticals Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Therapeutic Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Therapeutic Radiopharmaceuticals Market Size by Application (2015-2020)
    • 5.1.1 Global Therapeutic Radiopharmaceuticals Sales by Application (2015-2020)
    • 5.1.2 Global Therapeutic Radiopharmaceuticals Revenue by Application (2015-2020)
    • 5.1.3 Therapeutic Radiopharmaceuticals Price by Application (2015-2020)
  • 5.2 Therapeutic Radiopharmaceuticals Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Therapeutic Radiopharmaceuticals Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Therapeutic Radiopharmaceuticals Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Therapeutic Radiopharmaceuticals by Country
    • 6.1.1 North America Therapeutic Radiopharmaceuticals Sales by Country
    • 6.1.2 North America Therapeutic Radiopharmaceuticals Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Therapeutic Radiopharmaceuticals Market Facts & Figures by Type
  • 6.3 North America Therapeutic Radiopharmaceuticals Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Therapeutic Radiopharmaceuticals by Country
    • 7.1.1 Europe Therapeutic Radiopharmaceuticals Sales by Country
    • 7.1.2 Europe Therapeutic Radiopharmaceuticals Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Therapeutic Radiopharmaceuticals Market Facts & Figures by Type
  • 7.3 Europe Therapeutic Radiopharmaceuticals Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Therapeutic Radiopharmaceuticals by Region
    • 8.1.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region
    • 8.1.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Therapeutic Radiopharmaceuticals Market Facts & Figures by Type
  • 8.3 Asia Pacific Therapeutic Radiopharmaceuticals Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Therapeutic Radiopharmaceuticals by Country
    • 9.1.1 Latin America Therapeutic Radiopharmaceuticals Sales by Country
    • 9.1.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Therapeutic Radiopharmaceuticals Market Facts & Figures by Type
  • 9.3 Central & South America Therapeutic Radiopharmaceuticals Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Therapeutic Radiopharmaceuticals by Country
    • 10.1.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country
    • 10.1.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Therapeutic Radiopharmaceuticals Market Facts & Figures by Type
  • 10.3 Middle East and Africa Therapeutic Radiopharmaceuticals Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Therapeutic Radiopharmaceuticals Products Offered
    • 11.1.5 Bayer Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description, Business Overview and Total Revenue
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Therapeutic Radiopharmaceuticals Products Offered
    • 11.2.5 Novartis Recent Development
  • 11.3 China Isotope & Radiation
    • 11.3.1 China Isotope & Radiation Corporation Information
    • 11.3.2 China Isotope & Radiation Description, Business Overview and Total Revenue
    • 11.3.3 China Isotope & Radiation Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Products Offered
    • 11.3.5 China Isotope & Radiation Recent Development
  • 11.4 Dongcheng
    • 11.4.1 Dongcheng Corporation Information
    • 11.4.2 Dongcheng Description, Business Overview and Total Revenue
    • 11.4.3 Dongcheng Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Dongcheng Therapeutic Radiopharmaceuticals Products Offered
    • 11.4.5 Dongcheng Recent Development
  • 11.5 Q BioMed
    • 11.5.1 Q BioMed Corporation Information
    • 11.5.2 Q BioMed Description, Business Overview and Total Revenue
    • 11.5.3 Q BioMed Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Q BioMed Therapeutic Radiopharmaceuticals Products Offered
    • 11.5.5 Q BioMed Recent Development
  • 11.6 Curium Pharmaceuticals
    • 11.6.1 Curium Pharmaceuticals Corporation Information
    • 11.6.2 Curium Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.6.3 Curium Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 11.6.5 Curium Pharmaceuticals Recent Development
  • 11.7 Jubilant DraxImage
    • 11.7.1 Jubilant DraxImage Corporation Information
    • 11.7.2 Jubilant DraxImage Description, Business Overview and Total Revenue
    • 11.7.3 Jubilant DraxImage Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Products Offered
    • 11.7.5 Jubilant DraxImage Recent Development
  • 11.8 Lantheus
    • 11.8.1 Lantheus Corporation Information
    • 11.8.2 Lantheus Description, Business Overview and Total Revenue
    • 11.8.3 Lantheus Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Lantheus Therapeutic Radiopharmaceuticals Products Offered
    • 11.8.5 Lantheus Recent Development
  • 11.9 Spectrum Pharmaceuticals
    • 11.9.1 Spectrum Pharmaceuticals Corporation Information
    • 11.9.2 Spectrum Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.9.3 Spectrum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 11.9.5 Spectrum Pharmaceuticals Recent Development
  • 11.10 Progenics Pharmaceuticals
    • 11.10.1 Progenics Pharmaceuticals Corporation Information
    • 11.10.2 Progenics Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.10.3 Progenics Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Products Offered
    • 11.10.5 Progenics Pharmaceuticals Recent Development
  • 11.1 Bayer
    • 11.1.1 Bayer Corporation Information
    • 11.1.2 Bayer Description, Business Overview and Total Revenue
    • 11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Bayer Therapeutic Radiopharmaceuticals Products Offered
    • 11.1.5 Bayer Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Therapeutic Radiopharmaceuticals Market Estimates and Projections by Region
    • 12.1.1 Global Therapeutic Radiopharmaceuticals Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Therapeutic Radiopharmaceuticals Revenue Forecast by Regions 2021-2026
  • 12.2 North America Therapeutic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.2.1 North America: Therapeutic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.2.2 North America: Therapeutic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.2.3 North America: Therapeutic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Therapeutic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Therapeutic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.3.2 Europe: Therapeutic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Therapeutic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Therapeutic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Therapeutic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Therapeutic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Therapeutic Radiopharmaceuticals Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Therapeutic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Therapeutic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Therapeutic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Therapeutic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Therapeutic Radiopharmaceuticals Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Therapeutic Radiopharmaceuticals Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Therapeutic Radiopharmaceuticals Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Therapeutic Radiopharmaceuticals Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Therapeutic Radiopharmaceuticals Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Therapeutic Radiopharmaceuticals market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Therapeutic Radiopharmaceuticals market is segmented into
    Radium-223
    Lutetium-177
    Iodine-131
    Other

    Segment by Application, the Therapeutic Radiopharmaceuticals market is segmented into
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

    Regional and Country-level Analysis
    The Therapeutic Radiopharmaceuticals market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Therapeutic Radiopharmaceuticals market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Therapeutic Radiopharmaceuticals Market Share Analysis
    Therapeutic Radiopharmaceuticals market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Radiopharmaceuticals business, the date to enter into the Therapeutic Radiopharmaceuticals market, Therapeutic Radiopharmaceuticals product introduction, recent developments, etc.
    The major vendors covered:
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

    Buy now